The headline for 37 °C in 2018 is Digitalising health. In addition to plenary sessions there will be parallel sessions on Digitalising healthcare, Digitalisation in biotech, a Venture Session and Workshops on specific topics. 37 ºC has a carefully crafted program, a stimulating exhibition, B2B meetings and venture session.
Norway has one of the strongest and most admired health-related personal data registries and is a unique location for development of machine learning and artificial intelligence applications for the healthcare sector.
Please find the layout of the conference center underneath the program.
Day 1 – June 19th
| 09:00 |
10:00 |
Registration & Coffee |
Plenary session. Venue: Lysefjorden (A+B)
| 10:00 |
10:18 |
Opening and welcome addresses |
| Venue |
Lysefjorden (A+B) |
| Speakers |
10:00-10:04: Arne Hansson Rannestad, General Manager 37 °C
10:04-10:11: Christine Sagen Helgø, Mayor of Stavanger
10:11-10:18: Bent Høie, Norwegian Minister of Health and Care Services |
| 10:18 |
10:25 |
Co-Chairs’ Introduction
|
| Venue |
Lysefjorden (A+B) |
Co-Chairs
|
- Jon Harald Kaspersen, PhD, Research Director at SINTEF
- Henrik Lund, CEO Regenics AS, Chairman Of The Board Oslo Cancer Cluster 2008-2018
|
| 10:25 |
11:05 |
Keynote |
| Venue |
Lysefjorden (A+B) |
| Keynote speaker |
Erik Halvorsen, Director at TMCx Accelerator, Texas Medical Center |
| Description |
Organised in partnership with Greater Stavanger |
| 11:05 |
11:35 |
Coffee break, Mingling and visit Exhibition
|
| 11:35 |
12:15 |
Panel: Precision medicine will transform the entire pharmaceutical value chain from research, development, market authorization, to product launch and post-marketing monitoring. |
| Venue |
Lysefjorden (A+B) |
| Speakers |
- Rajji Mehdwan, General Manager Roche Norway, Roche
- Duarte Marchand, Country manager in Norway, Takeda
- Kirsten Haugland, Head of departement for Research and Prevention, The Norwegian Cancer Society
- Steinar Madsen, Medical director at Norwegian Medicines Agency
|
| Description |
How will regulatory, reimbursement and business models need to evolve and adapt to encourage innovation while ensuring maximum value is delivered to patients. |
| Moderator |
Stephen McAdam, Global Healthcare Director, at DNV GL |
| 12:15 |
13:20 |
Lunch, Mingling and visit Exhibition
|
Venue: Lysefjorden B: Digitalising healthcare (Parallel session)
Co-Chair: Jon Harald Kaspersen
| 13:20 |
13:25 |
Co-Chair’s Introduction
|
| Venue |
Lysefjorden B |
Co-Chair
|
- Jon Harald Kaspersen, PhD, Research Director at SINTEF
|
| 13:25 |
14:05 |
Panel: Unifying primary and secondary healthcare, and bringing the doctor to your living room with technology |
| Venue |
Lysefjorden B |
| Speakers |
- Thomas Lindner, MD, PhD, Director RAKOS – The Regional Centre for Emergency Medical Research and Development
- Josep Carbó, Business Developer at Mediktor Corp.
- Bjarte Bøe, Head of welfare technology at City of Stavanger
- Thorleif Jansen, Medical Director at KRY
- Dr. Oliver Heinze, Researcher, Entrepreneur, Vice Director, Department of Medical Information Systems, University Hospital Heidelberg
|
| Description |
Technology that bridges primary and secondary healthcare and that brings the hospital to our homes. Availibility versus accuracy, human contact and security. |
| Moderator |
Arild Kristensen, CEO of the Norwegian Smart Care Cluster |
| 14:05 |
14:45 |
Panel: The hospital of the future |
| Venue |
Lysefjorden B |
| Speakers |
- Sebastian Eckl, Dr. Med. from Siemens Healthineers AS
- Erik Halvorsen, Director at TMCx Accelerator, Texas Medical Center
- Anund Rannestad, VP International Sales and Partner Development at Imatis AS
- Sølve Johannessen, Partner at Attensi AS
|
| Description |
How a hospital would ideally look like and function if technology were applied in an optimal way. How the use of simulators, augmented reality (AR), virtual reality (VR), robotics is impacting education, training, patient consultancy, staff and organisation. |
| Moderator |
Finn Holm, Partner at EY |
Venue: Lysefjorden A: Digitalisation in biotech (Parallel session)
Co-Chair: Henrik Lund
| 13:20 |
13:25 |
Co-Chair’s Introduction
|
| Venue |
Lysefjorden A |
Co-Chair
|
- Henrik Lund, CEO Regenics AS, Chairman Of The Board Oslo Cancer Cluster 2008-2018
|
| 13:25 |
14:05 |
Panel: In silico medicine |
| Venue |
Lysefjorden A |
| Speakers |
- Joakim Sundnes, Associate Professor and Chief Research Scientist at Simula Research Laboratory
- Marianne Fyhn, Associate Professor at Oslo University
- Stig Omholt, Professor NTNU
- Rod Hose, Professor at the University of Sheffield
|
| Description |
Predictive or “in silico medicine” is the use of computer modelling and simulation in the diagnosis, treatment, prevention of a disease and development of products. Listen to researchers and experts within the field discuss how digitalization will transform medicine and what huge possibilities that lays in the future! |
| Moderator |
Eulalie Landèche, R&D Scientist at Novadiscovery |
| 14:05 |
14:45 |
Panel: Utilizing Norwegian health registries for technology development; BigData and personalized medicine – opportunities for both corporates and startups. |
| Venue |
Lysefjorden A |
| Speakers |
- Suzy Scholl, Coordinator of Translational Program in Gynecological Cancer and Head of RAIDS CONSULTING
- Oddgeir Holmen, IT Project Manager, HUNT Research Centre, Dept. of Public Health and Gen. Practice, NTNU
- Morten L. Isaksen, PhD, CEO, Bio-Me AS
- Jan Nygård, CIO at The Cancer Registry of Norway
- Matti Ristimäki, Head of Data-driven Health in Tieto
|
| Description |
The Norwegian health registries have a huge role to play in order to help develop AI and machine learning. |
| Moderator |
Ketil Widerberg, CEO of Oslo Cancer Cluster |
| 14:45 |
15:00 |
Coffee break, Mingling and visit Exhibition |
Venue: Lysefjorden A: Workshop
| 15:00 |
15:05 |
Co-Chairs’ Introduction |
| Venue |
Lysefjorden A |
| Co-Chairs |
- Jon Harald Kaspersen, PhD, Research Director at SINTEF
- Henrik Lund, CEO Regenics AS, Chairman Of The Board Oslo Cancer Cluster 2008-2018
|
| 15:05 |
16:30 |
Workshop: How can we accelerate innovation within biotech and life science and use digitalization as a facilitator? |
| Venue |
Lysefjorden A |
| Speakers |
- Ina K Dahlsveen, Senior Adviser, Research Council of Norway
- Laurent Saunier, Head of Departement of Life Science, Vinnova Sweden
- Steinar Thoresen, Medical Director, Abbvie
- Ingrid Teigland Akay, Managing Partner Hadean Ventures
|
| Description |
How digital technology can make innovation more efficient and shorten the commercialisation processes. |
| Moderator |
Anders Haugland, Managing Director, Bergen Teknologioverføring AS |
Venue: Lysefjorden B: Venture Session
| 15:00 |
16:30 |
Venture Session |
| Venue |
Lysefjorden B |
| Companies |
Investor Panel:
- Walter Stockinger MS, PhD / Managing Partner at Hadean Ventures
- Dan Shwarzman / CEO of MindUP Digital Health Incubator
- Martin Klint Hansen / Director, Novo Nordisk
- Otto Frøseth / Investment Director at Investinor AS
- William Young, Partner of Bridge Innovation Capital
- Øivind Enger, Partner in Sarsia Seed Management AS
Companies:
- Age Labs
- Bio-Me
- iNANOD
- MicroA
- ROWIAK GmbH
- SmartSens
- Astralution
|
| Description |
Companies will have 5 minutes to pitch and 5 minutes for Q&A by the Investor Panel and the audience. |
| Moderator |
Martin Svangtun / Chairman, Online Logistics AS |
Venue: Vårlivarden (1st floor): Workshop
(NB. Starting after lunch)
| 13:25 |
14:30 |
Workshop: Food is the new medicine. Hosted by TLSC. (PART 1/2) |
| Venue |
Vårlivarden (1st floor) |
| Introduction |
13:25-13:30: Marius Øgaard, Managing Director at The Life Science Cluster |
| Speaker (30 min) |
13:30-14:00: Rupert Osborn, CEO IP Pragmatics Limited |
| Technology presentations (35 min) |
14:00-14:15: Jens Nordahl, VP Sales & Marketing at Smartfish medical nutrition with omega 3
14:!5-14:30: Trond Helgerud, Alginate and Carrageenan R&D Manager, Managing Director FMC BioPolymer AS |
| Description |
“Let food be thy medicine and medicine be thy food.” Hippocrates (460-377 B.C.). Food is a most important factor in the prevention of disease. It is also an important complement to medicine, to cure disease. Now convergence is coming to the healthcare market!
Is there an indispensable important missing link between food and medicine as of yet? If such a missing link is Nutraceuticals, what about the market potential? Why would Nutraceuticals be indispensable?
October 2011 the following could be read in Time Magazine: ”World renowned economists predict in the next ten years, the Nutraceutical Industry will expand to over One Trillion Dollars ; meaning it`s going to be the largest growing industry in the next decades” and furthermore: ”The growing Nutraceutical Business will rise to, and even surpass, the existing pharma-business”.
– Companies from food production, aquaculture, agriculture, biotech and nutraceuticals will probably all turn their focus to this new booming health market
How can Norway’s food industry enter the worlds new booming one trillion dollar health market? |
| Moderator |
Marius Øgaard, Managing Director at The Life Science Cluster |
Venue: Vårlivarden (1st floor): Workshop
| 15:00 |
16:20 |
Workshop: Food is the new medicine. Hosted by TLSC (PART 2/2) |
| Venue |
Vårlivarden (1st floor) |
| Technology presentations (25 min) |
15:00-15:15: Egil Greve, CEO at Kappa bioscience, Vitamin K-2
15:15-15:30: Sjur Svaboe, CEO Biolink Group/Kristian Larsen COO Biolink Group, Medpalett: The percentage of people 60+ increases dramatically, demanding an impossible large amount of national budgets. When food is not thy medicine, and medicines is not thy food, what`s the solution?
15:30-15:45: Roar Feedt, AM Nutrition
15:45-16:00: Per Berg and Marianne S Markussen, Nortura ASA |
| Panel discussion (20 min) |
- Rupert Osborn, CEO IP Pragmatics Limited
- Egil Greve, CEO at Kappa bioscience, Vitamin K-2
- Sjur Svaboe, CEO Biolink Group
- Per Berg
|
| Description |
“Let food be thy medicine and medicine be thy food.” Hippocrates (460-377 B.C.). Food is a most important factor in the prevention of disease. It is also an important complement to medicine, to cure disease. Now convergence is coming to the healthcare market!
Is there an indispensable important missing link between food and medicine as of yet? If such a missing link is Nutraceuticals, what about the market potential? Why would Nutraceuticals be indispensable?
October 2011 the following could be read in Time Magazine: ”World renowned economists predict in the next ten years, the Nutraceutical Industry will expand to over One Trillion Dollars ; meaning it`s going to be the largest growing industry in the next decades” and furthermore: ”The growing Nutraceutical Business will rise to, and even surpass, the existing pharma-business”.
– Companies from food production, aquaculture, agriculture, biotech and nutraceuticals will probably all turn their focus to this new booming health market
How can Norway’s food industry enter the worlds new booming one trillion dollar health market? |
| Moderator |
Marius Øgaard, Managing Director at The Life Science Cluster |
Venue: Snønuten (1st floor): B2B Meetings
| 12:15 |
17:00 |
B2B Meetings, schedule meetings here.
|
| Venue |
Snønuten |
| Description |
Start networking here (opening soon), and set up your meetings now. |
Social Venue: We would like to invite All Participants to an informal gathering at Hall Toll, downtown Stavanger.
| 19:30 |
21:00 |
Social Venue: We would like to invite You to an informal gathering at Hall Toll, downtown Stavanger. Please join us and take the opportunity to meet with other Participants in a casual environment. We enjoy special prices untill 22:00. Link to map: Click here.
If you want to book a table for dinner at Hall Toll, please book Your table: Click here. Phone:+4751517232, Email: booking@hall-toll.no. Stavanger taxi: +4751909090. |
Day 2 – June 20th
Plenary session. Venue: Lysefjorden (A+B)
| 08:30 |
09:30 |
Registration & Coffee |
| 09:30 |
09:35 |
Co-Chairs’ Introduction
|
| Venue |
Lysefjorden (A+B) |
Co-Chairs
|
- Jon Harald Kaspersen, PhD, Research Director at SINTEF
- Henrik Lund, CEO Regenics AS, Chairman Of The Board Oslo Cancer Cluster 2008-2018
|
| 09:35 |
10:15 |
Incentivising researchers to commercialise new inventions |
| Venue |
Lysefjorden (A+B) |
| Speakers |
|
| Moderator |
Anders Haugland, Managing Director, Bergen Teknologioverføring AS |
| 10:15 |
10:50 |
Let food be your medicine – Healthy Nutrition in the age of digitalization |
| Venue |
Lysefjorden (A+B) |
| Keynote speaker |
Dr. Norbert Windhab, Vice President Strategic Projects in Health Care at Evonik Industries AG |
| 10:50 |
11:20 |
Coffee break, Mingling and visit Exhibition |
| 11:20 |
12:00 |
Panel: Utilising personal health and patient data in perspective of ethics and security – sharing is caring? |
| Venue |
Lysefjorden (A+B) |
| Speakers |
- Chunming Rong, Co-chair of IEEE Blockchain, Chair of IEEE Cloud Computing, CTO of Dataunitor, CTO of bitYoga, Head of CIPSI center at the University of Stavanger
- Gard O Sundby Thomassen, Assistant Director of Division for Research Computing at the University of Oslo Center for Information Technology
- Saara Malkamäki, Specialist at Sitra – The Finish Innovation Fund
|
| Description |
How to utilise personal health and patient data in an ethically and security-wise sound manner. |
| Moderator |
Kathrine Myhre, CEO Norway Health Tech |
| 12:00 |
12:40 |
Panel: 3D Bioprinting and Biofabrication
|
| Venue |
Lysefjorden (A+B) |
| Speakers |
- Nieves Cubo Mateo, MsC, Spanish National Research Council UCM/CSIC
- Michael GELINSKY, Prof. Dr., Professor and Head, Center for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden
|
| Description |
The three-dimensional fabrication of biological structures, tissues, and organs for research, drug-screening, and regenerative applications. |
| Moderator |
Marita Rodriguez, PhD, Biomedical Scientist and Engineer |
| 12:40 |
13:45 |
Lunch, Mingling and visit Exhibition |
Venue: Lysefjorden B: Digitalising healthcare (Parallel session)
Co-Chair: Jon Harald Kaspersen
| 13:45 |
13:50 |
Co-Chair’s Introduction
|
| Venue |
Lysefjorden B |
Co-Chair
|
- Jon Harald Kaspersen, PhD, Research Director at SINTEF
|
| 13:50 |
14:30 |
Panel: AI and machine learning – the doctors best friend? |
| Venue |
Lysefjorden B |
| Speakers |
- Sebastian Eckl, Dr. Med. from Siemens Healthineers AS
- Stein Ørn, MD, PhD, Stein Ørn, Professor Stein Ørn, MD, PhD, University of Stavanger and Senior Consultant Cardiology department at Stavanger University Hospital
- Emiel Janssen, PhD, Head quantitative and molecular pathology; Managing director laboratory for molecular biology; Head of research group at Department for Pathology at Stavanger University Hospital
- Steinar Thoresen, Medical Director at Abbvie
|
| Description |
How can technology enhance the quality and capability of medical personell and healthcare. Examples. |
| Moderator |
Trygve Eftestøl, Professor at University of Stavanger, Head of health technology research group |
| 14:30 |
15:10 |
Remotely controlled surgery vs. Drilling operations |
| Venue |
Lysefjorden B |
| Speakers |
- Einar Leirvik, Project Manager, Marine Cybernetics Advisory at DNV GL
- Ilangko Balasingham, PhD, Professor/Head of Biomedical Sensor Network Research Group, NTNU & Oslo University Hospital – Rikshospitalet
- Jacob Bergsland, MD, PhD, Cardiac Surgeon, Oslo University Hospital – Rikshospitalet
|
| Description |
Tech transfer between the petroleum industry and the health care sector. |
| Moderator |
Jon Harald Kaspersen, PhD, Research Director at SINTEF; Nordic Co-Chair of 37 °C |
Venue: Lysefjorden A: Digitalisation in biotech (Parallel session)
Co-Chair: Henrik Lund
| 13:45 |
13:50 |
Co-Chair’s Introduction
|
| Venue |
Lysefjorden A |
Co-Chair
|
- Henrik Lund, CEO Regenics AS, Chairman Of The Board Oslo Cancer Cluster 2008-2018
|
| 13:50 |
14:30 |
Panel: Are new antibiotics the solution to the AMR threat? |
| Venue |
Lysefjorden A |
| Speakers |
- John Sigurd Mjøen Svendsen, Professor, UiT The arctic university of Norway
- Pia Abel zur Wiesch, Researcher, UiT The arctic university of Norway
- Enrico Baraldi, Professor, Uppsala University/PLATINEA/DriveAB
- Alexander Wentzel, Senior Research Scientist, SINTEF
- Kirsten Haugland, Head of departement for Research and Prevention, The Norwegian Cancer Society
|
| Description |
Antibiotics have started to fail and resistance has become one of the greatest threats to global health, causing more than 500,000 deaths every year. If radical actions are not taken, this number is predicted to rise dramatically in the near future. But what is actually required to solve this huge problem? Are new antibiotics alone the only answer? |
| Moderator |
Frode Forland, Specialist director Infection Control and Environmental Health, Norwegian Institute of public health |
| 14:30 |
15:10 |
Panel: Re-thinking healthcare |
| Venue |
Lysefjorden A |
| Speakers |
- Tamara Mansfeld, Global Innovation Lead, Pfizer
- Umair Aslam, eHealth Lead of MSD Norway
- Hogne Titlestad, Founder and CEO of Friend Software Labs
- Kirsten Haugland, Head of department at Kreftforeningen and Board Member of Oslo Cancer Cluster
|
| Description |
How are digital technologies reshaping healthcare, value chains and business models of pharma companies? How are new technology changing the way we deliever health care? How is it transforming our financial structures? |
| Moderator |
Erling Nordbø, CEO Aleap Incubator for Health startups |
Stay one day extra and take a hike to the Pulpit Rock, more info here.
Layout Stavanger Forum
![]()
